Advertisement pradeep, Author at Pharmaceutical Business review - Page 2 of 2

Advertisement

Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Cambrex to buy Halo Pharma for $425m

The acquisition will allow Cambrex to enter the dosage form CDMO market. Halo Pharma is majority owned by funds managed by the private investment firm SK Capital Partners.